The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...
Introduction State of the Art Dengue Vaccine Development Challenges in Dengue Vaccine Development Emerging Opportunities for Advancing Dengue Vaccine References State of the Art Dengue Vaccine ...
News Medical on MSN1d
The growing list of human viruses: Are we prepared for the next outbreak?Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...
Under pressure to rebuild as sales of its blockbuster Lantus slide, Sanofi desperately needed the launch of its Dengue vaccine to run smoothly. But it hasn’t. Analysts had expected blockbuster ...
A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...
The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue ...
A research team has unveiled new insights into how weather influences the spread of dengue fever. The study identifies temperature and rainfall as critical factors driving the global surge in dengue ...
The Pan American Health Organization (PAHO) is warning that a dengue strain, the DENV-3 serotype, is on the rise in the Caribbean which could lead to a potential increase in cases of the disease. It ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback